Inhibition of CCR5-dependent HIV-1 infection by hairpin ribozyme gene therapy against CC-chemokine receptor 5

Virology

Volumn 276, Issue 2, 2000, Pages 271-278

  Feng, Yu ^a   Leavitt, Mark ^a   Tritz, Richard ^a   Duarte, Elizabeth ^a   Kang, David ^a   Mamounas, Michael ^a   Gilles, Patrick ^a   Wong Staal, Flossie ^b   Kennedy, Scott ^c   Merson, James ^d   Yu, Mang ^a   Barber, Jack R ^a  

^a Immusol Inc   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CHEMOKINE; CHEMOKINE RECEPTOR CCR5; MESSENGER RNA; RIBOZYME; VIRUS VECTOR;

ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DISEASE COURSE; GENE DELETION; GENE THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS STRAIN;

EID: 0034715552     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0536     Document Type: Article

References (39)

1. Genetic co-inactivation of macrophage- and T-tropic HIV-1 chemokine coreceptors CCR-5 and CXCR-4 by intrakines
2. HIV entry and tropism: The chemokine receptor connection
3. + T-cell lines vs. primary macrophages
4. Impact of heterozygosity for the chemokine receptor CCR5 32-bp-deleted allele on plasma virus load and CD4 T lymphocytes in perinatally human immunodeficiency virus-infected children at 8 years of age
5. + T cells
6. Inactivation of HIV-1 chemokine co-receptor CXCR-4 by a novel intrakine strategy
7. Cloning and functional expression of a human eosinophil CC chemokine receptor
8. Expression cloning of new receptors used by simian and human immunodeficiency viruses
9. A mechanism of resistance to HIV-1 entry: Inefficient interactions of CXCR4 with CD4 and gp120 in macrophages
10. Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1)
11. Shift of clinical human immunodeficiency virus type 1 isolates from X4 to R5 and prevention of emergence of the syncytium-inducing phenotype by blockade of CXCR4
12. Heterozygosity for a deletion in the CKR-5 gene leads to prolonged AIDS-free survival and slower CD4 T-cell decline in a cohort of HIV-seropositive individuals
13. Sequence specific cleavage of the HIV-1 coreceptor CCR5 gene by a hammer-head ribozyme and a DNA-enzyme: Inhibition of the coreceptor function by DNA-enzyme
14. A hammerhead ribozyme targeted to the human chemokine receptor CCR5
15. The hairpin ribozyme: Discovery, two-dimensional model, and development for gene therapy
16. RNA catalytic properties of the minimum (-)sTRSV sequence
17. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
18. Evidence for cell-surface association between fusin and the CD4-gp120 complex in human celt lines
19. STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1
20. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection
21. + T-cell clone (PM1): Failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1
22. Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes
23. Co-receptors for HIV-1 entry
24. Inhibition of human immunodeficiency virus type 1 expression by a hairpin ribozyme
25. Relative resistance to HIV-1 infection of CD4 lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposure
26. + lymphocytes from exposed-uninfected individuals: Association with low expression of CCR5 and high production of betachemokines
27. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression
28. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene
29. Molecular cloning and functional expression of a new human C-C-chemokine receptor gene
30. A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication
31. Inhibition of HIV replication by the hairpin ribozyme
32. A potential therapeutic application of hairpin ribozymes: In vitro and in vivo studies of gene therapy for hepatitis C virus infection
33. Intracellular application of hairpin ribozyme genes against hepatitis B virus
34. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
35. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro
36. Constitutive cell surface association between CD4 and CCR5
37. Anti-HIV type 1 activity of wild-type and functional defective RANTES intrakine in primary human lymphocytes
38. A hairpin ribozyme inhibits expression of diverse strains of human immunodeficiency virus type 1
39. Progress toward gene therapy for HIV infection